GO:0009987 | cellular process | 26.86% (47/175) | 1.48 | 0.0 | 0.0 |
GO:0008150 | biological_process | 30.29% (53/175) | 1.19 | 0.0 | 1e-06 |
GO:0005575 | cellular_component | 14.86% (26/175) | 1.4 | 5e-06 | 0.000837 |
GO:0110165 | cellular anatomical entity | 12.0% (21/175) | 1.55 | 1e-05 | 0.001205 |
GO:0044237 | cellular metabolic process | 14.29% (25/175) | 1.15 | 0.000146 | 0.008893 |
GO:0016192 | vesicle-mediated transport | 3.43% (6/175) | 2.93 | 0.000135 | 0.009355 |
GO:0033043 | regulation of organelle organization | 1.71% (3/175) | 4.69 | 0.000173 | 0.009358 |
GO:0003674 | molecular_function | 29.71% (52/175) | 0.68 | 0.000206 | 0.010007 |
GO:0051128 | regulation of cellular component organization | 1.71% (3/175) | 4.56 | 0.000236 | 0.010438 |
GO:0000313 | organellar ribosome | 1.14% (2/175) | 6.43 | 0.000134 | 0.010832 |
GO:0005761 | mitochondrial ribosome | 1.14% (2/175) | 6.43 | 0.000134 | 0.010832 |
GO:0048518 | positive regulation of biological process | 1.71% (3/175) | 4.43 | 0.000312 | 0.010842 |
GO:0048522 | positive regulation of cellular process | 1.71% (3/175) | 4.43 | 0.000312 | 0.010842 |
GO:0071840 | cellular component organization or biogenesis | 4.0% (7/175) | 2.46 | 0.000292 | 0.011824 |
GO:0031334 | positive regulation of protein-containing complex assembly | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0044089 | positive regulation of cellular component biogenesis | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0010638 | positive regulation of organelle organization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0030838 | positive regulation of actin filament polymerization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0045010 | actin nucleation | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0007015 | actin filament organization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0005885 | Arp2/3 protein complex | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:1902905 | positive regulation of supramolecular fiber organization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0097435 | supramolecular fiber organization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0005856 | cytoskeleton | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0051495 | positive regulation of cytoskeleton organization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0032273 | positive regulation of protein polymerization | 1.14% (2/175) | 5.43 | 0.00079 | 0.012388 |
GO:0019783 | ubiquitin-like protein-specific protease activity | 1.71% (3/175) | 3.93 | 0.000925 | 0.013222 |
GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity | 1.71% (3/175) | 3.93 | 0.000925 | 0.013222 |
GO:0101005 | ubiquitinyl hydrolase activity | 1.71% (3/175) | 3.93 | 0.000925 | 0.013222 |
GO:0071704 | organic substance metabolic process | 14.29% (25/175) | 0.94 | 0.001206 | 0.016745 |
GO:0006508 | proteolysis | 3.43% (6/175) | 2.31 | 0.001326 | 0.016956 |
GO:0051130 | positive regulation of cellular component organization | 1.14% (2/175) | 5.11 | 0.001307 | 0.017167 |
GO:0043170 | macromolecule metabolic process | 10.86% (19/175) | 1.11 | 0.001288 | 0.017389 |
GO:0043229 | intracellular organelle | 5.71% (10/175) | 1.82 | 0.000584 | 0.017724 |
GO:0043226 | organelle | 5.71% (10/175) | 1.82 | 0.000584 | 0.017724 |
GO:0008152 | metabolic process | 17.14% (30/175) | 0.88 | 0.000771 | 0.020811 |
GO:0022402 | cell cycle process | 1.71% (3/175) | 4.02 | 0.000768 | 0.021963 |
GO:0030833 | regulation of actin filament polymerization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0090066 | regulation of anatomical structure size | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0051493 | regulation of cytoskeleton organization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0032535 | regulation of cellular component size | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0044087 | regulation of cellular component biogenesis | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0032970 | regulation of actin filament-based process | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:1902903 | regulation of supramolecular fiber organization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0032271 | regulation of protein polymerization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0005783 | endoplasmic reticulum | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0110053 | regulation of actin filament organization | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0043254 | regulation of protein-containing complex assembly | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0030832 | regulation of actin filament length | 1.14% (2/175) | 4.62 | 0.002703 | 0.023046 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.29% (4/175) | 2.76 | 0.002857 | 0.023937 |
GO:0004843 | thiol-dependent ubiquitin-specific protease activity | 1.14% (2/175) | 4.85 | 0.001945 | 0.024243 |
GO:0019538 | protein metabolic process | 6.86% (12/175) | 1.3 | 0.003664 | 0.028268 |
GO:0043933 | protein-containing complex subunit organization | 1.71% (3/175) | 3.26 | 0.003654 | 0.028646 |
GO:0044265 | cellular macromolecule catabolic process | 1.71% (3/175) | 3.26 | 0.003654 | 0.028646 |
GO:1903047 | mitotic cell cycle process | 1.14% (2/175) | 4.43 | 0.003576 | 0.028969 |
GO:0006807 | nitrogen compound metabolic process | 11.43% (20/175) | 0.95 | 0.003544 | 0.029195 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1.71% (3/175) | 3.43 | 0.002594 | 0.029318 |
GO:0008234 | cysteine-type peptidase activity | 1.71% (3/175) | 3.43 | 0.002594 | 0.029318 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.71% (3/175) | 3.43 | 0.002594 | 0.029318 |
GO:0019941 | modification-dependent protein catabolic process | 1.71% (3/175) | 3.43 | 0.002594 | 0.029318 |
GO:0032991 | protein-containing complex | 5.14% (9/175) | 1.54 | 0.003998 | 0.030358 |
GO:1901564 | organonitrogen compound metabolic process | 8.57% (15/175) | 1.11 | 0.004273 | 0.031946 |
GO:0044260 | cellular macromolecule metabolic process | 8.0% (14/175) | 1.15 | 0.00452 | 0.032785 |
GO:0009057 | macromolecule catabolic process | 1.71% (3/175) | 3.16 | 0.004489 | 0.033052 |
GO:0005509 | calcium ion binding | 1.71% (3/175) | 3.11 | 0.004945 | 0.035344 |
GO:0044238 | primary metabolic process | 12.57% (22/175) | 0.85 | 0.005086 | 0.035822 |
GO:0070011 | peptidase activity, acting on L-amino acid peptides | 2.86% (5/175) | 2.17 | 0.005179 | 0.035955 |
GO:0050794 | regulation of cellular process | 4.0% (7/175) | 1.71 | 0.00568 | 0.037303 |
GO:0043167 | ion binding | 10.86% (19/175) | 0.92 | 0.005481 | 0.037519 |
GO:0016043 | cellular component organization | 2.86% (5/175) | 2.14 | 0.005649 | 0.037606 |
GO:0003824 | catalytic activity | 15.43% (27/175) | 0.74 | 0.005632 | 0.038018 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0051985 | negative regulation of chromosome segregation | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0051784 | negative regulation of nuclear division | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0045839 | negative regulation of mitotic nuclear division | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0007094 | mitotic spindle assembly checkpoint | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0007093 | mitotic cell cycle checkpoint | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0030041 | actin filament polymerization | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0031577 | spindle checkpoint | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0008154 | actin polymerization or depolymerization | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0033046 | negative regulation of sister chromatid segregation | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0010948 | negative regulation of cell cycle process | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0071173 | spindle assembly checkpoint | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0071174 | mitotic spindle checkpoint | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0051259 | protein complex oligomerization | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0035145 | exon-exon junction complex | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0051499 | D-aminoacyl-tRNA deacylase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0002161 | aminoacyl-tRNA editing activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0004506 | squalene monooxygenase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0003713 | transcription coactivator activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0000702 | oxidized base lesion DNA N-glycosylase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0019104 | DNA N-glycosylase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0005815 | microtubule organizing center | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:1905819 | negative regulation of chromosome separation | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0051258 | protein polymerization | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0098518 | polynucleotide phosphatase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0004651 | polynucleotide 5'-phosphatase activity | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0099513 | polymeric cytoskeletal fiber | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0099512 | supramolecular fiber | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0099081 | supramolecular polymer | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0099080 | supramolecular complex | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0005876 | spindle microtubule | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0005874 | microtubule | 0.57% (1/175) | 6.43 | 0.011597 | 0.042061 |
GO:0050789 | regulation of biological process | 4.0% (7/175) | 1.68 | 0.006553 | 0.04246 |
GO:0008233 | peptidase activity | 2.86% (5/175) | 2.08 | 0.006677 | 0.042698 |
GO:0042254 | ribosome biogenesis | 1.14% (2/175) | 3.97 | 0.006866 | 0.043338 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.71% (3/175) | 2.93 | 0.007046 | 0.043904 |
GO:0065007 | biological regulation | 4.0% (7/175) | 1.5 | 0.01248 | 0.044928 |
GO:0035091 | phosphatidylinositol binding | 1.14% (2/175) | 3.52 | 0.012716 | 0.04544 |
GO:0005488 | binding | 17.14% (30/175) | 0.66 | 0.007839 | 0.048223 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.71% (3/175) | 2.85 | 0.008267 | 0.048406 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.71% (3/175) | 2.85 | 0.008267 | 0.048406 |
GO:0044085 | cellular component biogenesis | 1.14% (2/175) | 3.85 | 0.008177 | 0.049062 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.14% (2/175) | 3.85 | 0.008177 | 0.049062 |